Our customer stories
Immunocore is a leading T Cell Receptor (TCR) biotechnology company focused on delivering first-in-class biological therapies that have the potential to transform the lives of people with serious diseases.
Adaptimmune, a leader in T-cell therapy, has clinical trials ongoing for three wholly owned SPEAR T-cells (ADP-A2M4 (MAGE-A4), ADP-A2M10 (MAGE-A10), and ADP-A2AFP (AFP)) in multiple solid tumor indications. The Company’s unique SPEAR (Specific Peptide Enhanced Affinity Receptor) T‑cell platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The foundation of our TCR therapies is the work we did with NY-ESO SPEAR T-cells, which we transitioned to GSK in 2018, showing responses in two solid tumors and treating more than 90 patients in six different indications.
“I’ve had the pleasure of working with Aigenpulse for the past year.
Aigenpulse is an extraordinary data management and analytics platform that enables us to efficiently
streamline processes and place an even greater focus on research.”
“Aigenpulse enables my team access to all of our research data, coherently structured, integrated and linked across the organisation from one easy to use interface.”
Are you ready to unlock the power of your data?
Speak to one of our scientists to discuss how The Aigenpulse Platform can accelerate, augment and empower your drug discovery.
Aigenpulse works together with these great organisations.
OBN is the not-for-profit Membership organisation supporting and bringing together the UK’s life sciences companies, corporate partners and investors. Our 400-plus Member companies are located across the Golden Triangle and beyond to Manchester, Nottingham, the Midlands, South Coast and Scotland, benefiting from our networking, partnering, purchasing, training, advising and advocacy activities.
Established in 1997, One Nucleus is an award winning not-for-profit Life Sciences & Healthcare membership organisation centred on the Greater London-Cambridge-East of England corridor. Headquartered in Cambridge, at the heart of Europe’s largest Life Sciences & Healthcare cluster, we support those institutions, companies and individuals undertaking activity in or with the above region.
The Pistoia Alliance is a global, not-for-profit members’ organization conceived in 2007 and incorporated in 2009 by representatives of AstraZeneca, GSK, Novartis and Pfizer who met at a conference in Pistoia, Italy. This group shared the opinion that life science R&D was changing beyond recognition, and that organizations could not afford to ‘go it alone’ in order to integrate emerging technologies and continue to deliver life-changing therapies to patients. The Pistoia Alliance’s projects help to overcome common obstacles to innovation and to transform R&D – whether identifying the root causes of inefficiencies, working with regulators to adopt new standards, or helping researchers implement AI effectively. There are currently more than 100 member companies – ranging from global organisations to medium enterprises, to start-ups, to individuals – collaborating as equals on projects that generate value for the worldwide life sciences community.
Google Cloud delivers secure, open, intelligent, and transformative tools to help enterprises modernize for today’s digital world.